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University College of Medicine, Seoul 120-752, Republic of KoreaThe His723Arg (H723R) mutation in SLC26A4, encoding pen-
drin, is the most prevalent mutation in East Asia, resulting in
DFNB4, an autosomal recessive type of genetic hearing loss.
Although the main pathological mechanism of H723R was
identified as a protein-folding defect in pendrin, there is still
no curative treatment for associated hearing loss. Here, we
show that H723R-pendrin expression and activity are rescued
by activation of the chaperonin DNAJC14. In vitro, DNAJC14
was activated via Japanese encephalitis virus (JEV) inoculation,
and toxin-attenuated JEV rescued the surface expression and
anion exchange activity of H723R-pendrin. Human H723R-
pendrin transgenic mice (hH723R Tg) were established in a
mouse slc26a4 knockout background, in which only hH723R-
pendrin was expressed in the inner ear (Pax2-Cre dependent)
to mimic human DFNB4 pathology. Crossing hH723R Tg
with DNAJC14-overexpressing mice resulted in reduced
cochlear hydrops and more preserved outer hair cells in the
cochlea compared to those in hH723R Tg mice. Furthermore,
the stria vascularis and spiral ligament were thicker and
KCNJ10 expression was increased with DNAJC14 overexpres-
sion; however, hearing function and enlarged endolymphatic
hydrops were not recovered. These results indicate that
DNAJC14 overexpression ameliorates the cochlear degenera-
tion caused by misfolded pendrin and might be a potential
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SLC26A4 encodes pendrin protein, which is an anion exchanger in
the inner ear.1–3 Mutations in SLC26A4 cause non-syndromic,
autosomal recessive hearing loss (DFNB4), which is the most com-
mon cause of congenital deafness in east and south Asia.4–9 In Ko-
rea, the allele frequency of the major variants of SLC26A4 that
cause DFNB4 is very high, specifically as much as approximately
0.7%, upon referring to the gnomAD database (http://gnomad.
broadinstitute.org/). DFNB4 results in congenital, fluctuating, pro-
gressive, and severe-to-profound sensorineural hearing loss.10
Vestibular functions are also impaired and linked to hearing loss188 Molecular Therapy: Methods & Clinical Development Vol. 17 June 2
This is an open access article under the CC BY-NC-ND license (httpin patients with DFNB4.11 Most patients with DFNB4 have
congenital and severe hearing loss and, thus, undergo cochlear
implantation and require hearing rehabilitation. Although residual
hearing is often observed at an early age, there is a limited window
of several years to remedy or prevent hearing loss during the early
stage.12 Unfortunately, no curable treatment options are currently
available for the sensorineural hearing loss that occurs with
DFNB4.
Among the pathogenic mutations in the protein encoded by
SLC26A4, p.H723R (His723Arg) in pendrin is the most common
among Korean and Japanese populations.5,13,14 The pathological
mechanism of p.H723R is related to protein misfolding, retention
in the endoplasmic reticulum (ER), and degradation by ER-associated
degradation (ERAD) pathway.15,16 Recent studies have shown that
misfolded proteins can be expressed on the cellular surface via an
unconventional secretion pathway comprising Golgi-bypassing
trafficking under ER stress.16–18 Thus, p.H723R-pendrin (H723R-
pendrin) can be rescued on the cell surface via this unconventional
trafficking pathway, which is mediated by Hsp70 and its co-chap-
erone DNAJC14. Hsp70 and DNAJC14 then interact with H723R-
pendrin and retrieve the misfolded pendrin from the ERAD pathway
to deliver it to the cell surface.16
DNAJC14 is an ER chaperonin that modulates the cell-surface traf-
ficking of dopamine D1 receptor and SNARE complex-mediated lyso-
somal trafficking.19,20 Interestingly, DNAJC14 also modulates RNA
replication for viruses of the Flaviviridae family after infection in
mammalian cells.21 This protein is activated by Flavivirus infection
and is recruited to the virus replication complex, where it mediates viral020 ª 2019 The Authors.
://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Rescue of hH723R-Pendrin Expression and Function by Japanese Encephalitis Virus (JEV)
(A) Surface biotinylation assays were performed in PANC-1 cells expressing hH723R-pendrin. Blockade of endoplasmic reticulum (ER-to-Golgi traffic via Arf1-Q71L
overexpression induced the cell-surface expression of core-glycosylated H723R-pendrin (band B). Overexpression of DNAJC14 (3 HA-tagged) alone or with Hsc70 (Myc-
tagged) induced the cell-surface expression of core-glycosylated H723R-pendrin in PANC-1 cells. (B) Surface biotinylation assay in PANC-1 cells transfected with plasmids
encoding wild-type (WT)- and hH723R-pendrin after treatment with JEV (106 pfu). Band B, ER core-glycosylated immature pendrin; band C, fully glycosylated mature
pendrin. The first lane is the positive control cells, in which the band C form of WT-pendrin was expressed on the cell surface. The second lane is the negative control cells, in
which the cell-surface band C form of hH723R-pendrin was not expressed and the band B formwas weakly expressed. The last lane is cells treated with JEV (106 pfu), which
induced the cell-surface expression of the band B form of hH723R-pendrin on the cell surface. (C) The surface expression ratio of pendrin (compared to total lysate pendrin)
was significantly increased by JEV treatment (106 pfu) (n = 8 in each group). ***p < 0.001. (D) Cl/HCO3
 exchange activity measured by recording the pH-sensitive
fluorescent probe 20,70-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) in PANC-1 mock cells and in WT- and hH723R-pendrin stably expressing cells, as
detailed in the Materials and Methods. (E) The quantitation of multiple experiments showed that the Cl/HCO3
 exchange activity was significantly increased in the cells
expressing hH723R-pendrin with JEV (3  106 pfu) treatment (n = 6 in each group). **p < 0.01.
www.moleculartherapy.orgreplication on the ER membranes by affecting viral polyprotein pro-
cessing through the promotion of protein folding.21–23 This phenom-
enon is highly reminiscent of the unconventional trafficking of
H723R-pendrin via the Hsp70/DNAJC14 machinery in terms of pro-
tein folding and trafficking from the ER to the cell surface.16 Therefore,
we hypothesized that the administration of a Flavivirus such as yellow
fever virus or Japanese encephalitis virus (JEV) would activate the
Hsp70/DNAJC14 machinery to enhance the unconventional traf-
ficking of H723R-pendrin and subsequently rescue the function of
pendrin. We tested this hypothesis using an in vitro model of JEV-in-
fected human pancreatic cancer cell line (PANC-1) cells expressing
H723R-pendrin. Furthermore, we investigated the effect of enhanced
DNAJC14 on changes in inner ear histology and auditory function
in human p.H723R-pendrin (hH723R) transgenic (Tg) mice andMoleculDNAJC14-overexpressing mice, mimicking the pathology of hearing
loss associated with human DFNB4.
RESULTS
JEV Rescues the Expression and Function of hH723R-Pendrin
We previously reported that H723R-pendrin has a folding defect and
is rescued by DNAJC14 overexpression.16 Here, we also observed
that the surface expression of hH723R-pendrin was increased in a
DNAJC14-dependent manner (Figure 1A). Next, we investigated
the effect of JEV on the trafficking of hH723R-pendrin, given that
Flavivirus species such as JEV activate DNAJC14. In line with our
hypothesis, when stable PANC-1 cells expressing hH723R-pendrin
were treated with toxin-attenuated JEV, the surface expression of
hH723R-pendrin significantly increased, whereas the levels ofar Therapy: Methods & Clinical Development Vol. 17 June 2020 189
Figure 2. Japanese Encephalitis Virus (JEV) Restores
the Expression of Cell-Surface hH723R-Pendrin
Cell-surface pendrin expression was examined in
PANC-1 cells with immunostaining. (A) The cells were
stained for pendrin (anti-Flag, green) and co-stained for
DNAJC14 (red). Nuclei were counterstained with DAPI.
DIC images were overlapped in the second lane to
clarify the boundary of cells (dashed line). Yellow arrow
line indicates the axis for the quantification of fluores-
cence. In the lower panel, fluorescence intensities for
pendrin (green) and DAPI (blue) were quantified along
the long axis of each cell, where the yellow box refers to
the position of the plasma membrane. Scale bar,
20 mm. (B) The plasma membrane fraction of pendrin
was calculated as fluorescence signals between a
distance of 5 mm from the cell membrane-to-total
fluorescence signal in the cell. Compared to that in lane
2 (hH723R-pendrin), both groups treated with JEV at
different titers (1  104 and 5  104 pfu) showed
increased expression of pendrin in the cell membrane
(n = 4). ***p < 0.001.
Molecular Therapy: Methods & Clinical DevelopmenthH723R-pendrin and DNAJC14 in the lysate were not changed,
indicating improved trafficking efficiency to the membrane surface
(Figures 1B and 1C).
We also investigated the anion-exchange activity of pendrin with the
treatment of JEV according to changes in the fluorescence curve of
the pH-sensitive fluorescent probe 20,70-bis-(2-carboxyethyl)-5-
(and-6)-carboxyfluorescein (BCECF), as described previously.14
The pH increased when the extracellular solution was changed
from 129 mM Cl to 0 mM Cl, owing to the influx of extracellular
HCO3
. Strong Cl/HCO3
 exchange activity was also elicited by
transfection with human wild-type (WT)-pendrin but not with
hH723R-pendrin. Notably, the compromised anion exchange activity
(Cl/HCO3
) of hH723R-pendrin was significantly increased by JEV
treatment (Figures 1D and 1E). The effect of the JEV treatment was
also consistent when we measured formate and bicarbonate
(HCO2
/HCO3
) exchange activity (Figures S1A and S1B). Immu-
nostaining showed that hH723R-pendrin was restricted to the ER
but that WT-pendrin was well expressed on the cellular surface (Fig-
ure 2). With variable amounts of JEV (10 or 50 mL of a 106 pfu/mL
suspension), the membrane surface fraction of hH723R-pendrin
remarkably increased (Figures 2A, lower panel, and 2B). Taken
together, these results suggest that JEV treatment, which activates
DNAJC14, increases the cell-surface expression and anion-exchange
activity of hH723R-pendrin.
DNAJC14 Ameliorates Structural Degeneration in hH723R Tg(+)
Mice
To evaluate the pathology of DFNB4 with DNAJC14 activation for
potential therapeutic development, the DFNB4 mouse model ex-
pressing H723R-pendrin was used. To establish an H723R mouse190 Molecular Therapy: Methods & Clinical Development Vol. 17 June 2model with deafness, we first generated H723R knockin in mice (Fig-
ure S2A–S2C). However, hearing function in these mice remained
normal, and there were no abnormalities in the inner ear (Figures
S2D and S2E), consistent with results of a previous study.24 Thus,
we established hH723R Tg mice (strain name, B6-Tg(CMV-
SLC26A4tm1)1JJ, allele1: H723R (c.2139G >A)) in a mouse
slc26a4 homozygous knockout (mPDS/) (strain name, 129S-
Slc26a4tm1Egr/AjgJ) background. The hH723R-flanked transgene
(Figure S3A) was designed and inoculated into the embryos of B6
mice, which were then crossed with Pax2-Cre mice to achieve inner
ear- and kidney-specific expression of hH723R-pendrin. The
hH723R Tg mice were subsequently crossed with mPDS/ mice to
only express hH723R in the inner ear and kidney, without the expres-
sion of mouse pendrin. As a positive control, we also established hu-
man WT-pendrin Tg (hPDS Tg; strain name, B6-Tg(CMV-
SLC26A4)0JJ) mice. Western blotting confirmed ectopic expression
of WT-pendrin in the kidney and cochlea but not in the liver and in-
testine (Figure S3B, left panel). In hH723R Tgmice, hH723R-pendrin
was identified in the cochlea (Figure S3B, right panel). hPDS Tg mice
were underweight, and their lifespan was limited to only 2 months,
which might be attributable to the ectopic overexpression of pendrin
in the kidneys causing kidney dysfunctions such as electrolyte
imbalance.
The auditory brainstem response (ABR) test demonstrated deafness
in the hH723R Tg mice, mimicking human DFNB4, whereas
the hPDS Tg mice showed normal hearing (Figure S3C). Cochlear
histology clearly identified cochlear hydrops in both mPDS/ and
hH723R Tg(+);mPDS/ mice, but not in hPDS Tg(+);
mPDS/ mice ubiquitously expressing ectopic WT-pendrin in the
cochlea (Figure S3D). Based on whole-mount images and surface020
Figure 3. Overexpression of DNAJC14 in hH723R-Pendrin Transgenic Mouse
(A) For activation of DNAJC14 in the established hH723R-pendrin transgenic (hH723R Tg) mouse model, hH723R Tg mice were crossed with Tg mice overexpressing
DNAJC14. (B) Based on western blotting of the cochlea, expression of pendrin was increased by overexpressing DNAJC14. (C) Quantification of the density of pendrin is
depicted in (AU, arbitrary unit) (n = 4 in each group). *p < 0.05. (D) DNAJC14 expression (red) was identified in the DNAJC14 Tg(+);hH723R Tg(+);mPDS(/) mice, and the
expression of pendrin was increased in most of the cochlear tissue (Pax2-Cre dependent), as shown by immunostaining using the Alexa 488 secondary antibody (green).
DAPI (blue) was used for nuclear staining. Scale bar, 100 mm; sm, scala media; st, scala tympani; sv, scala vestibule.
www.moleculartherapy.orgelectron microscopy of cochlear hair cells, the outer and inner
hair cells were more preserved in hH723R Tg(+);mPDS/ mice
than in mPDS/ mice, indicating that the ectopic expression
of hH723R in the inner ear was minimally helpful to maintain
cochlear structure and function (Figure S3E). Finally, hH723R
Tg(+);mPDS/mice showed enlarged endolymphatic sacs and ducts
compared to those in hPDS Tg(+);mPDS/ animals based on
computed tomogram sagittal images (Figure S3F). Taken together,
we considered that hH723R Tg(+);mPDS/ mice effectively mimic
human pathologies associated with DFNB4, such as deafness.
For the activation of DNAJC14, we crossed hH723R Tg(+);
mPDS/ mice with Tg mice overexpressing DNAJC14 (DNAJC14
Tg(+); strain name, B6-Tg(CMV-DNAJC14)2JJ) (Figure 3A). Over-
expression of DNAJC14 was confirmed in the cochlea, and the
expression of hH723R-pendrin was also increased in the
cochlea (Figures 3B and 3C). Because the hH723R Tg mouse model
is dependent on Pax2-Cre expression, most of the cochlear tissue
was positive for ectopic pendrin expression (Figure 3D). With
respect to histological changes, the cochlear hydrops was signifi-
cantly reduced when DNAJC14 was overexpressed in the cochleaMolecul(Figures 4A and 4B), and the stria vascularis and spiral ligament
in DNAJC14 Tg(+);hH723R Tg(+);mPDS/ mice were more pre-
served and thicker when compared to those of hH723R Tg mice
(Figures 4C–4E). In addition, degeneration of the outer hair cells
in hH723R Tg mice was mitigated by the expression of DNAJC14
(Figures 4F and 4G) and KCNJ10, which is important for the gener-
ation of endocochlear potential, was more preserved in the stria vas-
cularis with DNAJC14 overexpression (Figures 4H and 4I). Collec-
tively, these results indicate that DNAJC14 ameliorates cochlear
degeneration in hH723R Tg mice.
Meanwhile, when we measured the hearing thresholds based on the
ABR, DNAJC14 overexpression did not ameliorate hearing function
with respect to auditory thresholds in click and frequency-specific
stimuli (Figures 5A and 5B). Furthermore, we observed that the
ectopic expression of hH723R in the endolymphatic duct, endolym-
phatic sac, and ampulla of the semi-circular canal increased with
DNAJC14 overexpression (Figure 5C). However, the enlarged
endolymphatic duct and sac were not restored with DNAJC14
overexpression. In addition, the giant otoconia identified in
hH723R Tg(+);mPDS/ mice was also observed in DNAJC14ar Therapy: Methods & Clinical Development Vol. 17 June 2020 191
Figure 4. Comparison of Cochlear Histology and KCNJ10 Expression in Mice with Different Genotypes
(A) H&E staining of cochlea fromwild-type (WT),mPDS/, hH723R Tg(+);mPDS/, and DNAJC14 Tg(+);hH723R Tg(+);mPDS/mice at 4–5 weeks of agewas performed.
(B) Cochlear hydrops in DNAJC14 Tg(+);hH723R Tg(+);mPDS/ mice were significantly reduced (n = 6 mice in each group). **p < 0.01; WT, wild-type; KO, mPDS/. (C)
The stria vascularis (SV) and spiral ligament (SL) depth were thicker in DNAJC14 Tg(+);hH723R Tg(+);mPDS/mice than in hH723R Tg(+);mPDS/mice. (D) SV depth was
statistically compared (n = 6mice in each group). (E) SL depth was statistically compared (n = 6mice in each group). (F) Whole-mount of cochlear outer hair cells (OHC) at the
middle turn. (G) DNAJC14 expression increased the number of OHCs (n = 6mice in each group). WT, wild-type; KO,mPDS/. (H) KCNJ10 (green) immunostaining showed
increased expression of KCNJ10 in the stria vascularis, implying that the endocochlear potential might have been partially rescued. DAPI (blue) was used for nuclear staining.
Scale bar, 100 mm. (I) KCNJ10 fluorescence histogram of multiple area sections of the stria vascularis (n = 3). * p < 0.05.
Molecular Therapy: Methods & Clinical DevelopmentTg(+);hH723R Tg(+);mPDS/ mice. These data indicate that
DNAJC14 overexpression was not sufficient to ameliorate hearing
loss and vestibular malformation, including enlarged vestibular aque-
duct and abnormal otoconia formation.
DISCUSSION
Genetic hearing loss is highly prevalent, with an incidence of 1 in
500–1,000 children.25 More than half of all cases of congenital hear-
ing loss are caused by genetic variants. However, there is still no
clinically curative treatment option for patients with genetic hearing
loss. Because mutations in SLC26A4, encoding pendrin, are the
most common cause of deafness in East Asia, it is important to
develop effective therapeutics for patients with DFNB4 or Pendred
syndrome.
We previously demonstrated that DNAJC14 is the key modulator
that rescues the misfolded pendrin proteins from the ERAD and
consequently enhances its expression and function.16 DNAJC14 is192 Molecular Therapy: Methods & Clinical Development Vol. 17 June 2an ER chaperonin that plays various physiological roles in mamma-
lian cells, including the trafficking of dopamine D1 receptor and the
lysosome function.19,20 Interestingly, DNAJC14 also appears to
play a role in viral RNA replication in mammalian cells infected
with Flavivirus species such as yellow fever virus and JEV.21,23
Although the specific functional interaction underlying the mecha-
nism through which DNAJC14 mediates the RNA replication of
Flavivirus remains unknown, it seems clear that DNAJC14 is acti-
vated and rearranged on the ER membrane in response to Flavivirus
infection. The present study demonstrated that DNAJC14 assists
with the proper folding of misfolded pendrin, thereby facilitating
its escape from the ER to the membrane surface. Thus, we reasoned
that activated DNAJC14 due to Flavivirus infection might also
promote the protein folding of H723R-pendrin. As expected, we
demonstrated that JEV infection increased the cellular surface
expression of H723R-pendrin, which was likely related to the pro-
motion of protein folding and rescue from ERAD. This finding sug-
gests the possible application of attenuated Flavivirus, as with the020
Figure 5. DNAJC14 Overexpression Results in the Insufficient Rescue of Hearing Function and Vestibular Abnormal Morphologies in hH723R Transgenic
Mice
(A and B) Auditory brainstem responses by click and tone-burst stimuli were measured in wild-type (WT), hH723R Tg(+);mPDS/, and DNAJC14 Tg(+);hH723R Tg(+);-
mPDS/mice. Auditory threshold was not recovered even if DNAJC14 was overexpressed in hH723R Tg(+);mPDS/mice based on click (A) and tone-burst (B) stimuli (n =
8 mice in each group). (C) Immunostaining of endolymphatic duct, endolymphatic sac, and ampulla in P0 mice of each strain. hH723R-pendrin (green) was predominantly
identified in the epithelial lines (endolymphatic duct, endolymphatic sac, and ampulla) as well as supporting cells, around the endolymphatic duct and common crus (possibly
ectopic expression of pendrin depending on CMV promoter) of DNAJC14 Tg(+);hH723R Tg(+);mPDS/ mice. DNAJC14, red; DAPI, blue; ed, endolymphatic duct; cc,
common crus; es, endolymphatic sac; ca, crista ampullaris; cu, cupula; white arrow, ed in wild-type; scale bar, 100 mm. (D) Light microscopy and surface electron mi-
croscopy were used to observe otoconia morphology (red arrow). Giant otoconia were identified in the macula of hH723R Tg(+);mPDS/ mice (middle), whereas normal-
sized otoconia were observed in the macula of WT mice (upper). Giant otoconia were also observed in the macula of DNAJC14 Tg(+);hH723R Tg(+);mPDS/ mice (lower).
Scale bar, 100 mm.
www.moleculartherapy.orgstrategy used in vaccines, as a therapeutic modality for patients with
DFNB4 or Pendred syndrome.
Another important finding of this study is the establishment of a
mouse model of H723R mutation-related DFNB4. AlthoughMoleculseveral animal models with mutated pendrin have been re-
ported,26,27 it has thus far been a challenge to establish a suitable
H723R-pendrin mouse model with the human phenotype
including deafness.24 In this study, we successfully established an
hH723R-pendrin mouse model with deafness. This model canar Therapy: Methods & Clinical Development Vol. 17 June 2020 193
Molecular Therapy: Methods & Clinical Developmentthus serve as a useful research tool for drug screening and valida-
tion, as well as preclinical trials for hearing preservation drugs that
facilitate protein folding.
We also demonstrated that the overexpression of DNAJC14 in the
inner ear could ameliorate the histological degeneration caused by
the pendrin H723R mutation. Because slc26a4 knockout results in
an enlarged vestibular aqueduct and endolymphatic hydrops
in mice, bulging Reissner’s membrane in the cochlea due to dila-
tation of the scala media is typical.28 This finding was also
observed in hH723R Tg(+) mice, which led us to speculate that
patients with DFNB4 caused by the H723R mutation might
also have cochlear hydrops. Importantly, the size of the cochlear
hydrops in hH723R Tg(+) mice was significantly reduced by
DNAJC14 overexpression in the inner ear. This indicates
that rescued hH723R-pendrin can restore anion exchange (Cl/
HCO3
) activity in the epithelia lining the membranous labyrinth,
including the scala media, endolymphatic duct, and sac. We spec-
ulated that the partial expressional and functional rescue of
hH723R-pendrin makes a difference in the milieu of the endo-
lymph in terms of pH and endocochlear potential. Consequently,
outer hair cells, as well as cells in the stria vascularis, might
become more stable, and cell survival could increase. However,
the protective effect of DNAJC14 on inner ear histology appears
to be limited, as hearing loss and hydrops remained and hair
cell degeneration occurred over time. Given that DNAJC14 expres-
sion was not sufficient to overcome hydrops caused by embryolog-
ical defects in the hH723R Tg mouse model, hearing function
could not be recovered by DNAJC14 in these animals. In addition,
the vestibular phenotype, including circling and head tilting,
cannot be rescued by the overexpression of DNAJC14 in the inner
ear, and it is possible that the mixture of various background
strains might affect histological changes in the inner ear. Neverthe-
less, the hH723R Tg mouse model holds promise for utilization in
in vivo screens of small molecules that promote protein folding or
in gene therapy. In conclusion, we demonstrated that the activa-
tion or overexpression of DNAJC14 increases the surface expres-
sion and anion-exchange activity of hH723R-pendrin. This finding
sheds light on the development of therapeutics for genetic hearing
loss caused by SLC26A4 mutations.
MATERIALS AND METHODS
Cell Culture and Transfection
PANC-1 cells were maintained in DMEM-High Glucose (Lonza,
Walkersville, MD, USA) supplemented with 10% fetal bovine serum
(FBS) and penicillin (50 IU/mL)/streptomycin (50 mg/mL) at 37C
with 5% CO2. As previously described for HA-Arf1, pcDNA3-
HA-Arf1 and the corresponding empty expression vectors were
used for transfection experiments.17 Human DNAJC14, Hsc70
clones were purchased from Open Biosystems (Lafayette, CO,
USA) and subcloned into pCMV-myc or pCMV-Flag plasmids
(Clontech, Palo Alto, CA, USA).16 The expression plasmids for
WT- and H723R-pendrin were subcloned into pCMV-Flag plas-
mids (Clontech, Palo Alto, CA, USA). To establish PANC-1 cells194 Molecular Therapy: Methods & Clinical Development Vol. 17 June 2stably expressing WT-pendrin or hH723R-pendrin, each plasmid
was transfected into PANC-1 cells using Lipofectamine 2000 re-
agent (Invitrogen), and puromycin was used to select the transfected
cells during 10 passages.
Chemicals and Antibodies
The JEV Beijing-1 strain propagated in a mosquito cell line (C6/36)
was kindly supplied by Dr. S.K. Eo (Chonbuk University, Iksan,
Korea).29 Virus stocks (106 pfu/mL) were titrated using a conven-
tional plaque assay and stored in aliquots at 80C until use. The
anti-Flag antibody (F3165) was purchased from Sigma-Aldrich
(St. Louis, MO, USA). The anti-Myc-Hsc70 (1B5) and anti-DNAJC14
antibody (ab121535) were obtained from Abcam (Cambridge,
UK). The anti-pendrin (G-19), anti-aldolase (N-15), anti-3HA-
DNAJC14 (F-7), HA-arf1 (F-7), and anti-b-actin antibody (sc-
47778) were from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). The anti-KCNJ10 (Kir4.1, Kir1.2) antibody (APC-035) was
from Alomone Labs (Jerusalem, Israel).
Surface Biotinylation Assay
The surface proteins were biotinylated with sulfo-NHS-SS-biotin
(Pierce) for 30 min before cell lysis. The cells were washed with
quenching buffer containing 1% bovine serum albumin (BSA) and
then washed three times with phosphate-buffered saline (PBS). After
cell lysis with lysis buffer containing 50 mM tris-HCl (pH 8.0),
150 mM NaCl, 1% (v/v) Triton X-100, and complete protease inhib-
itor mixture (Roche Applied Science, Mannheim, Germany), the
lysates were incubated overnight at 4C with 10% NeutrAvidin beads
(Pierce). NeutrAvidin-bound biotinylated proteins were centrifuged
and washed three times with PBS and then eluted in 2 sodium
dodecyl sulfate (SDS) sample buffer. Protein samples were separated
by SDS-polyacrylamide gel electrophoresis. The separated proteins
were transferred to a nitrocellulose membrane and blotted with
appropriate primary and secondary antibodies. Protein bands were
detected by enhanced chemiluminescence.16
Measurement of pHi and Cl
–/HCO3
– exchange activity
The pHi in PANC-1 cells, which have minimal intrinsic anion ex-
change activity, was measured with a pH-sensitive fluorescent probe,
BCECF, as described previously.14 In brief, the pH-sensitive fluores-
cent probe BCECF was detected in PANC-1 cells transiently trans-
fected WT-pendrin or H723R-pendrin. After JEV treatment for 24
h, PANC-1 cells were incubated with 2 mM BCECF acetoxy-methyl-
ester for 15 min and then perfused with an HCO3
-buffered solution
(120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM
D-glucose, 5 mM HEPES, and 25 mM NaHCO3 [pH 7.4]). BCECF
fluorescence was recorded at the excitation wavelengths of 490 nm
and 440 nm at a resolution of 2/s on a recording setup (Carl-Zeiss
AxioObserver with Ex-ET436/ET495 and Em-ET540 filters and opti-
MOS CCD camera). Cl/HCO3
 exchange activities were estimated
from the initial rate of pH increase as a result of Cl removal in the
HCO3
-containing buffer (25 mM HCO3 with 5% CO2).
16 Cl-free
solutions were prepared by replacing chloride with equimolar gluco-
nate. For formate/HCO3
 exchange activity, Cl was replaced with020
www.moleculartherapy.orgformate. The signal of BCECF in cells perforated with nigericin
(5 mM) was calibrated with solutions of various pH levels (pH 6.2,
7.2, and 8.2). The buffer capacity of each cell was measured as
described previously.14 Data were analyzed with theMetafluor system
(Molecular Devices).
Immunocytochemistry
PANC-1 cells were cultured on coverslips. The cells were permeabi-
lized by incubation in cold ethanol and acetone (1:1) at 20C for
8 min and blocked by incubation with blocking medium (0.2 mL
PBS containing 5% normal donkey serum, 1% BSA, 0.1% gelatin,
and 0.001% NaAzide) at 20C for 1 h to block non-specific binding
sites. Subsequently, the cells were stained through incubation with
target-specific primary and secondary antibodies (Table S1). Cells
were viewed under an LSM780 confocal microscope (Zeiss Labora-
tories, Jena, Germany).
Animal Experiments
All experimental procedures were approved by Yonsei University
Health System Institutional Animal Care and Use Committee
(2016-0254). All mice were housed under specific pathogen-free con-
ditions at the animal facility of Yonsei University. All mice were
raised at a maximum density of five mice per cage and kept under a
12 h lighting cycle (ambient temperature 18C–23C, humidity
40%–60%, 12/12 h light/dark cycle, lights on at 8:00 a.m.). Breeding
mice were supplied with nesting materials. All mice were provided
with radicidation feed and reverse osmosis water. The cages were
ventilated and managed individually with an automatic watering sys-
tem. All experiments were performed with mice under general anes-
thesia with tiletamine and zolazepam (100 mg/kg) and xylazine
(50 mg/kg) via intraperitoneal injection.
Generation of the hH723R-Pendrin Mouse Model
The mouse pendrin H723R knockin mouse model was generated by
Macrogen (Seoul, Korea). The mice were generated using a homolo-
gous recombination approach as previously reported.24 The targeting
scheme is described in Figure S2A. The c.2168A>G mutation in exon
19 was targeted for the generation of H723R-PDS mice. Genotype
sequencing was performed with the sense primer 50-AGAACCTGAG
ATGGGGATTCATG-30 and antisense primer 50-AGCAAATGCCA
CATCCGTCAG-30 (size of amplicons, WT, 842 bp; knockin,
2,126 bp) (Figure S2B).
The human pendrin H723R Tg mouse model was established with a
Cre-inducible system, in which the LoxP-STOP-LoxP sequence from
pBigT, terminating transcription, was subcloned into the EcoRI site of
a pCA GGS vector, and the cDNA fragment encoding human
SLC26A4 (WT or c.2139G>A) was subsequently ligated using XhoI
and NotI sites. After confirmation of transgene expression in
HEK293T cells with CMV-Cre plasmid expression, the linearized
transgene construct was microinjected into pronuclear-stage mouse
embryos (C57BL/6N) and transferred to pseudopregnant mice. One
Tg founder mouse harboring human SLC26A4 (WT or c.2139G>A)
was identified by PCR amplification of tail genomic DNA and estab-Molecullished through germline transmission. Passage-3 hPDS Tg mice were
mated with slc26a4 knockout mice (kindly gifted by Prof. Sung Huhn
Kim) to eliminate mouse pendrin. hPDS Tg(+);mPDS/ mice were
then mated with Pax2-Cre(+) mice (strain name, B6-Tg(Pax2-cre)
1Akg/Mmnc [stock, MMRRC no. 010569], kindly gifted by Prof. Jin-
woong Bok) to generate mice with Pax2-specific expression of human
pendrin without mouse pendrin. The final genotype of mice used in
the experiments was hPDS Tg(+);Pax2-Cre(+);mPDS/, in which
only human pendrin (WT or hH723R) was expressed, but no mouse
pendrin was expressed in the inner ear. The genotyping for hPDS Tg,
hH723R Tg, Pax2-Cre Tg, and slc26a4 knockout mice was performed
with the following specific primers: human pendrin Tg, fwd 50-AAC
CATGTTCATGCCTTCTTC-30 and rev 50-CTAAAGCGCATGCTC
CAGA-30 (amplicon size: 226 bp); Pax2-Cre, fwd 50-GCCTGCATT
ACCGGTCGATGCAACGA-30 and rev 50- GTGGCAGATGGCGCG
GCAACACCATT-30 (amplicon size, 700 bp); slc26a4 KO, fwd 50-TG
CCGATTTCATCGCTGG-30, rev1 50-GCATTGTAGTTCTTTTCC
AAGTTGG-30 and Rev2 50- GGGTGCGGAGAAAGAGGTAATG-30
(WT, 287 bp; KO, 243 bp).
Inner Ear Western Blotting
Mice at approximately 4–5 weeks of age were anesthetized and then
perfused to remove all blood from the entire body. The inner ears
of the mice of each genotype were dissected, and then the tissues
were chopped and mashed in lysis buffer. After centrifugation of
the lysates, the supernatant was used for immunoblotting as described
previously herein.
Inner Ear Histology
Tissues from the inner ears of the mice were fixed in 4% parafor-
maldehyde at 4C overnight and then washed twice with PBS.
Subsequently, the specimens were decalcified in 25% EDTA/PBS
for 24 h. Tissues were dehydrated and embedded in paraffin for
histology and dissected into segments with the organ of Corti
and permeabilized with 0.1% Triton X-100 for whole-mount im-
munostaining. The paraffin blocks were cut into 5-mm sections
using a microtome (Leica Biosystems) and subjected to hematox-
ylin and eosin (H&E) staining and immunostaining. H&E-stained
tissues were examined under a light microscope. For immuno-
staining, paraffin sections were deparaffinized with xylene, ethanol,
and PBS. Thereafter, for antigen retrieval, the sections were incu-
bated in sodium citrate at 95C for 5 min and then blocked in 10%
normal donkey serum for 1 h at room temperature. The tissues
were incubated overnight with target-specific primary antibodies
at 4C, washed, and incubated for 1 h at room temperature with
the appropriate secondary antibody (Table S1). Finally, the sam-
ples were washed and then mounted with mounting solution
(Sigma-Aldrich, St. Louis, MO, USA). All images of immunostain-
ing were obtained under a confocal microscope LSM780 (Zeiss
Laboratories, Jena, Germany).
Whole-Mount Immunofluorescence
Whole-mount immunofluorescence of cochlea was performed as
described previously.30 In brief, isolated cochleas were obtainedar Therapy: Methods & Clinical Development Vol. 17 June 2020 195
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aldehyde at 4C overnight. After washing twice with PBS, the fixed
temporal bones were decalcified for 24 h in 10% ethylenediamine-
tetraacetic acid (EDTA)/PBS. For paraffin sectioning and H&E
staining, serial dehydration of the tissues was performed with
ethanol and xylene. Then, the tissues were either embedded in
paraffin for standard histological examination or dissected into
smaller pieces and permeabilized with 0.1% Triton X-100 for
whole-mount immunofluorescence. The paraffin blocks were
sliced into 5-mm-thick sections in the midmodiolar plane using a
microtome (Leica Biosystems, Nußloch, Germany). Deparaffiniza-
tion was performed on the sections and whole-mounted tissues
with a series of washes with xylene, ethanol, and PBS. After incu-
bation in tris-sodium citrate at 95C for antigen retrieval, the tis-
sues were blocked with 10% donkey serum and incubated with
target-specific primary and secondary antibodies at 4C overnight.
The samples were then mounted with mounting solution (Sigma-
Aldrich) and viewed under an LSM780 confocal microscope (Zeiss,
Jena, Germany).Auditory Function Test
ABR measurements were recorded as described previously.30 In brief,
tests were conducted using an ABR workstation manufactured by
Tucker Davis Technology (Alachua, FL, USA). Properly anesthetized
mice were placed on a heating pad (37C) in a soundproofed cham-
ber. After electrode insertion, acoustic stimuli were applied through a
receiver probe. The stimuli included 500 repeated click sounds or tone
bursts with a 1-ms rise and fall time and a 5-ms plateau at frequencies
of 4, 8, 16, and 32 kHz. The sound intensity began at a 90-dB sound
pressure level (SPL) with 5-dB decreasing steps to the auditory
threshold.Micro-computed Tomogram
A custom-built, transmission X-ray microCT scanner of medium en-
ergy was used (Model 1076, Skyscan, Aartselaar, Belgium) to obtain
images under the conditions of 100 kV of acceleration voltage. After
mice were fully anesthetized and fixed, the CT scan was performed.
Scanning minimized the changes in the position of the specimen dur-
ing repeated processes. The 2D images were analyzed using the CTAn
(Skyscan, Belgium) computer program.Scanning Electron Microscopy
Scanning electron microscopy was performed as described previ-
ously.30 Decalcified and fixed cochleas were immersed in 2% glutar-
aldehyde and paraformaldehyde in 0.1 M PBS, pH 7.4 for 6 h. After
washing twice in 0.1 M PBS for 30 min each, tissues were post-fixed
with 1% OsO4, dissolved in 0.1 M PBS for 1.5 h, and dehydrated in an
ascending gradual series (50%–100%) of ethanol. Tissues were then
treated with isoamyl acetate and subjected to critical point drying
with a Leica EM CPD300 (Vienna, Austria). Then they were coated
with Platinum (5 nm) using an ion coater (Leica EM ACE600) and
examined and photographed with a scanning electron microscope
(FE-SEM; Merin, Zeiss).196 Molecular Therapy: Methods & Clinical Development Vol. 17 June 2Statistical Analysis
The results of multiple experiments are presented as the means ±
SEM. Statistical comparisons were performed based on analysis of
variance followed by the Bonferroni multiple comparison test, where
appropriate; p < 0.05 was considered statistically significant.
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